

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.37426383 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.37426383 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.00012250 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.00012250 |
| 5 | fucose catabolic process (GO:0019317) | 6.85878379 |
| 6 | L-fucose metabolic process (GO:0042354) | 6.85878379 |
| 7 | L-fucose catabolic process (GO:0042355) | 6.85878379 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.52840057 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.83653180 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.83653180 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.83653180 |
| 12 | eosinophil chemotaxis (GO:0048245) | 5.83228737 |
| 13 | prenylation (GO:0097354) | 5.62931565 |
| 14 | protein prenylation (GO:0018342) | 5.62931565 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.60221139 |
| 16 | kynurenine metabolic process (GO:0070189) | 5.57760718 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.56421888 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.49631675 |
| 19 | cysteine metabolic process (GO:0006534) | 5.32680651 |
| 20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.29661567 |
| 21 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 5.16722970 |
| 22 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 5.16722970 |
| 23 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 5.16722970 |
| 24 | eosinophil migration (GO:0072677) | 5.15463495 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 5.10311071 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 4.98654613 |
| 27 | urea metabolic process (GO:0019627) | 4.81664093 |
| 28 | urea cycle (GO:0000050) | 4.81664093 |
| 29 | aromatic amino acid family metabolic process (GO:0009072) | 4.70768849 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.69217726 |
| 31 | bile acid metabolic process (GO:0008206) | 4.68805323 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.68708048 |
| 33 | high-density lipoprotein particle remodeling (GO:0034375) | 4.62025385 |
| 34 | regulation of protein activation cascade (GO:2000257) | 4.59962646 |
| 35 | negative regulation of fibrinolysis (GO:0051918) | 4.57603297 |
| 36 | protein carboxylation (GO:0018214) | 4.55971859 |
| 37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.55971859 |
| 38 | lysine metabolic process (GO:0006553) | 4.50167928 |
| 39 | lysine catabolic process (GO:0006554) | 4.50167928 |
| 40 | nitrogen cycle metabolic process (GO:0071941) | 4.49135093 |
| 41 | regulation of fibrinolysis (GO:0051917) | 4.46175054 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 4.43950141 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.43497077 |
| 44 | cellular ketone body metabolic process (GO:0046950) | 4.36932722 |
| 45 | coenzyme catabolic process (GO:0009109) | 4.35367484 |
| 46 | regulation of complement activation (GO:0030449) | 4.33418181 |
| 47 | homocysteine metabolic process (GO:0050667) | 4.31040377 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 4.27049370 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 4.22617100 |
| 50 | indolalkylamine metabolic process (GO:0006586) | 4.16823228 |
| 51 | regulation of triglyceride catabolic process (GO:0010896) | 4.15684011 |
| 52 | reverse cholesterol transport (GO:0043691) | 4.14682753 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 4.14597144 |
| 54 | glutamate metabolic process (GO:0006536) | 4.08800811 |
| 55 | cellular biogenic amine catabolic process (GO:0042402) | 4.08455304 |
| 56 | amine catabolic process (GO:0009310) | 4.08455304 |
| 57 | protein import into peroxisome matrix (GO:0016558) | 4.05669691 |
| 58 | aldehyde catabolic process (GO:0046185) | 4.03655078 |
| 59 | cellular modified amino acid catabolic process (GO:0042219) | 4.02126945 |
| 60 | cellular amino acid catabolic process (GO:0009063) | 4.01655309 |
| 61 | acetyl-CoA metabolic process (GO:0006084) | 4.00300584 |
| 62 | plasma lipoprotein particle remodeling (GO:0034369) | 3.98147758 |
| 63 | protein-lipid complex remodeling (GO:0034368) | 3.98147758 |
| 64 | macromolecular complex remodeling (GO:0034367) | 3.98147758 |
| 65 | triglyceride homeostasis (GO:0070328) | 3.97562156 |
| 66 | acylglycerol homeostasis (GO:0055090) | 3.97562156 |
| 67 | drug transmembrane transport (GO:0006855) | 3.96489909 |
| 68 | phospholipid efflux (GO:0033700) | 3.95725779 |
| 69 | serine family amino acid metabolic process (GO:0009069) | 3.93860684 |
| 70 | behavioral response to nicotine (GO:0035095) | 3.93468740 |
| 71 | bile acid and bile salt transport (GO:0015721) | 3.93089565 |
| 72 | ethanol oxidation (GO:0006069) | 3.92764818 |
| 73 | cellular glucuronidation (GO:0052695) | 3.87715563 |
| 74 | fucosylation (GO:0036065) | 3.87260594 |
| 75 | plasma lipoprotein particle clearance (GO:0034381) | 3.86885218 |
| 76 | fatty acid elongation (GO:0030497) | 3.86713698 |
| 77 | negative regulation of sterol transport (GO:0032372) | 3.84565387 |
| 78 | negative regulation of cholesterol transport (GO:0032375) | 3.84565387 |
| 79 | short-chain fatty acid metabolic process (GO:0046459) | 3.83502752 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 3.81513721 |
| 81 | cholesterol efflux (GO:0033344) | 3.80548170 |
| 82 | serine family amino acid biosynthetic process (GO:0009070) | 3.79975788 |
| 83 | ketone body metabolic process (GO:1902224) | 3.79623220 |
| 84 | autophagic vacuole fusion (GO:0000046) | 3.76251600 |
| 85 | urate metabolic process (GO:0046415) | 3.74389890 |
| 86 | imidazole-containing compound metabolic process (GO:0052803) | 3.74059116 |
| 87 | cofactor catabolic process (GO:0051187) | 3.71714598 |
| 88 | very long-chain fatty acid metabolic process (GO:0000038) | 3.70591331 |
| 89 | drug catabolic process (GO:0042737) | 3.68964360 |
| 90 | aspartate family amino acid catabolic process (GO:0009068) | 3.65690669 |
| 91 | regulation of mononuclear cell migration (GO:0071675) | 3.64713891 |
| 92 | uronic acid metabolic process (GO:0006063) | 3.60621595 |
| 93 | glucuronate metabolic process (GO:0019585) | 3.60621595 |
| 94 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.59563082 |
| 95 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.59542439 |
| 96 | glycine metabolic process (GO:0006544) | 3.56685253 |
| 97 | heme transport (GO:0015886) | 3.55395050 |
| 98 | organic acid catabolic process (GO:0016054) | 3.55180634 |
| 99 | carboxylic acid catabolic process (GO:0046395) | 3.55180634 |
| 100 | arginine metabolic process (GO:0006525) | 3.54495879 |
| 101 | organelle membrane fusion (GO:0090174) | 3.53365439 |
| 102 | low-density lipoprotein particle remodeling (GO:0034374) | 3.52580202 |
| 103 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.51794127 |
| 104 | fibrinolysis (GO:0042730) | 3.51770324 |
| 105 | sulfation (GO:0051923) | 3.48891883 |
| 106 | regulation of bile acid biosynthetic process (GO:0070857) | 3.48228745 |
| 107 | oxidative demethylation (GO:0070989) | 3.44289805 |
| 108 | complement activation, classical pathway (GO:0006958) | 3.41663216 |
| 109 | cholesterol homeostasis (GO:0042632) | 3.40688736 |
| 110 | regulation of cholesterol homeostasis (GO:2000188) | 3.40057415 |
| 111 | opsonization (GO:0008228) | 3.37625955 |
| 112 | sterol homeostasis (GO:0055092) | 3.37176142 |
| 113 | plasma lipoprotein particle assembly (GO:0034377) | 3.35820917 |
| 114 | fucose metabolic process (GO:0006004) | 3.34194487 |
| 115 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.33829468 |
| 116 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.33829468 |
| 117 | fatty acid beta-oxidation (GO:0006635) | 3.33639264 |
| 118 | complement activation (GO:0006956) | 3.32714938 |
| 119 | exogenous drug catabolic process (GO:0042738) | 3.32270335 |
| 120 | monocarboxylic acid catabolic process (GO:0072329) | 3.32091918 |
| 121 | cytolysis (GO:0019835) | 3.31797578 |
| 122 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.31077507 |
| 123 | protein targeting to vacuole (GO:0006623) | 3.30162376 |
| 124 | protein targeting to lysosome (GO:0006622) | 3.30162376 |
| 125 | establishment of protein localization to vacuole (GO:0072666) | 3.30162376 |
| 126 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.19014477 |
| 127 | flavonoid metabolic process (GO:0009812) | 3.15898152 |
| 128 | gonadal mesoderm development (GO:0007506) | 3.13756078 |
| 129 | negative regulation of Ras GTPase activity (GO:0034261) | 3.07434461 |
| 130 | regulation of glucokinase activity (GO:0033131) | 3.03184759 |
| 131 | regulation of hexokinase activity (GO:1903299) | 3.03184759 |
| 132 | adaptation of signaling pathway (GO:0023058) | 3.02789439 |
| 133 | negative regulation of mast cell activation (GO:0033004) | 3.02497751 |
| 134 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.01042519 |
| 135 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.98499965 |
| 136 | organ growth (GO:0035265) | 2.98044490 |
| 137 | regulation of sister chromatid cohesion (GO:0007063) | 2.91079698 |
| 138 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.90844477 |
| 139 | response to pheromone (GO:0019236) | 2.87824952 |
| 140 | neurotransmitter metabolic process (GO:0042133) | 2.85911181 |
| 141 | methionine biosynthetic process (GO:0009086) | 2.78629260 |
| 142 | cellular response to ATP (GO:0071318) | 2.75885013 |
| 143 | positive regulation of calcium ion import (GO:0090280) | 2.73464273 |
| 144 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.72827685 |
| 145 | cellular response to exogenous dsRNA (GO:0071360) | 2.72581101 |
| 146 | regulation of beta-amyloid formation (GO:1902003) | 2.71372082 |
| 147 | vesicle fusion (GO:0006906) | 2.70937144 |
| 148 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.70217725 |
| 149 | proline transport (GO:0015824) | 2.68341346 |
| 150 | serotonin metabolic process (GO:0042428) | 2.66124728 |
| 151 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.62937686 |
| 152 | cytidine metabolic process (GO:0046087) | 2.60274615 |
| 153 | cytidine catabolic process (GO:0006216) | 2.60274615 |
| 154 | cytidine deamination (GO:0009972) | 2.60274615 |
| 155 | neurotransmitter biosynthetic process (GO:0042136) | 2.60100276 |
| 156 | acrosome assembly (GO:0001675) | 2.56156232 |
| 157 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.53710996 |
| 158 | primary amino compound metabolic process (GO:1901160) | 2.53673078 |
| 159 | protein targeting to peroxisome (GO:0006625) | 2.53436215 |
| 160 | establishment of protein localization to peroxisome (GO:0072663) | 2.53436215 |
| 161 | protein localization to peroxisome (GO:0072662) | 2.53436215 |
| 162 | branch elongation of an epithelium (GO:0060602) | 2.52309985 |
| 163 | L-methionine salvage (GO:0071267) | 2.50855163 |
| 164 | L-methionine biosynthetic process (GO:0071265) | 2.50855163 |
| 165 | amino acid salvage (GO:0043102) | 2.50855163 |
| 166 | indole-containing compound metabolic process (GO:0042430) | 2.49409869 |
| 167 | positive regulation of fatty acid transport (GO:2000193) | 2.47824196 |
| 168 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.47131876 |
| 169 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.45292168 |
| 170 | positive regulation of fatty acid oxidation (GO:0046321) | 2.45154019 |
| 171 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.43062115 |
| 172 | regulation of guanylate cyclase activity (GO:0031282) | 2.41525218 |
| 173 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.41497785 |
| 174 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.41497785 |
| 175 | gamma-aminobutyric acid transport (GO:0015812) | 2.41049335 |
| 176 | GPI anchor metabolic process (GO:0006505) | 2.39848844 |
| 177 | parturition (GO:0007567) | 2.39756215 |
| 178 | DNA demethylation (GO:0080111) | 2.39414722 |
| 179 | detection of light stimulus involved in visual perception (GO:0050908) | 2.37743258 |
| 180 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.37743258 |
| 181 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.36818188 |
| 182 | intracellular pH reduction (GO:0051452) | 2.36516343 |
| 183 | sodium-independent organic anion transport (GO:0043252) | 2.35676826 |
| 184 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.35398062 |
| 185 | angiotensin maturation (GO:0002003) | 2.35110379 |
| 186 | sphingoid metabolic process (GO:0046519) | 2.34587888 |
| 187 | S-adenosylmethionine metabolic process (GO:0046500) | 2.33855137 |
| 188 | positive regulation of chromosome segregation (GO:0051984) | 2.33152878 |
| 189 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.32119253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.27110316 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.16234853 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.95117174 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.72819176 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.61296839 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.19181380 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.06221852 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.46599708 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.40412209 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 3.15023992 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.12850165 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.99703381 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.96969707 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.94371513 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.76421880 |
| 16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.44289607 |
| 17 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.40217722 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.31191098 |
| 19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.17553657 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.13558773 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.12061203 |
| 22 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.10982555 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.2752614 |
| 24 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89344806 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.85672182 |
| 26 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.83826177 |
| 27 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.79951353 |
| 28 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.78251995 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.75177122 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73360028 |
| 31 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.71691877 |
| 32 | P300_19829295_ChIP-Seq_ESCs_Human | 1.71265185 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.70757130 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69217305 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.68274964 |
| 36 | FUS_26573619_Chip-Seq_HEK293_Human | 1.68067048 |
| 37 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.67572722 |
| 38 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.59886867 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.57914940 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57810505 |
| 41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.56956015 |
| 42 | STAT3_23295773_ChIP-Seq_U87_Human | 1.56938202 |
| 43 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.52769830 |
| 44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.52720407 |
| 45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51077074 |
| 46 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.50238751 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49399028 |
| 48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43684035 |
| 49 | EWS_26573619_Chip-Seq_HEK293_Human | 1.41730755 |
| 50 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.40458750 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.40330875 |
| 52 | TCF4_23295773_ChIP-Seq_U87_Human | 1.38813743 |
| 53 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.37856822 |
| 54 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.36261663 |
| 55 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.35748043 |
| 56 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.35367308 |
| 57 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.34866870 |
| 58 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.34024017 |
| 59 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.33671666 |
| 60 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.31978212 |
| 61 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.31978212 |
| 62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30231366 |
| 63 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.29736606 |
| 64 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.29245090 |
| 65 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29245090 |
| 66 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.28064428 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27999301 |
| 68 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25981204 |
| 69 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.25636277 |
| 70 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.24732192 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23998251 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23998251 |
| 73 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23745183 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22746766 |
| 75 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21416984 |
| 76 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21194100 |
| 77 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20109519 |
| 78 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.19650659 |
| 79 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.19248271 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18503441 |
| 81 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.18133058 |
| 82 | RXR_22108803_ChIP-Seq_LS180_Human | 1.17651860 |
| 83 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.17617857 |
| 84 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.17617857 |
| 85 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16440657 |
| 86 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15717572 |
| 87 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13735974 |
| 88 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.13234408 |
| 89 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12588853 |
| 90 | KDM2B_26808549_Chip-Seq_REH_Human | 1.12148605 |
| 91 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12136246 |
| 92 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.11704390 |
| 93 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11222679 |
| 94 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11016082 |
| 95 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10619924 |
| 96 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.10459192 |
| 97 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.08447775 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08156163 |
| 99 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.07204778 |
| 100 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06588413 |
| 101 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.05077482 |
| 102 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.04915647 |
| 103 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.04564123 |
| 104 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.02975411 |
| 105 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02862582 |
| 106 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02304253 |
| 107 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.01368373 |
| 108 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.01164554 |
| 109 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00321348 |
| 110 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00078145 |
| 111 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99193648 |
| 112 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99160532 |
| 113 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98339626 |
| 114 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.97210326 |
| 115 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90600282 |
| 116 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90026141 |
| 117 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.89070866 |
| 118 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.85662006 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85473317 |
| 120 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84144813 |
| 121 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.83623280 |
| 122 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.82794371 |
| 123 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.82295755 |
| 124 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82265267 |
| 125 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80677483 |
| 126 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78149242 |
| 127 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77216052 |
| 128 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.76137699 |
| 129 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.74919349 |
| 130 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73918456 |
| 131 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70098564 |
| 132 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.69916389 |
| 133 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.69294493 |
| 134 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.68416888 |
| 135 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.68176787 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.67124426 |
| 137 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.67054390 |
| 138 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66982893 |
| 139 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.64939307 |
| 140 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.64491116 |
| 141 | CBP_21632823_ChIP-Seq_H3396_Human | 0.63312602 |
| 142 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.62885055 |
| 143 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.62501876 |
| 144 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.61606739 |
| 145 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.60174470 |
| 146 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.57804013 |
| 147 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56113243 |
| 148 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56096735 |
| 149 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.55046626 |
| 150 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.55012841 |
| 151 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.54047488 |
| 152 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52786200 |
| 153 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52487718 |
| 154 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.52222533 |
| 155 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.52216816 |
| 156 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.51564128 |
| 157 | NCOR_22424771_ChIP-Seq_293T_Human | 0.51324422 |
| 158 | GATA2_19941826_ChIP-Seq_K562_Human | 0.51279283 |
| 159 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.51109142 |
| 160 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.50979916 |
| 161 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.50596238 |
| 162 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.50582306 |
| 163 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.50004703 |
| 164 | GATA1_19941826_ChIP-Seq_K562_Human | 0.49981623 |
| 165 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.49964664 |
| 166 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.49394892 |
| 167 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.49299349 |
| 168 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49079532 |
| 169 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.48689062 |
| 170 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.48566294 |
| 171 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.48492458 |
| 172 | AR_20517297_ChIP-Seq_VCAP_Human | 0.48301521 |
| 173 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.48282147 |
| 174 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.47404859 |
| 175 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.47124737 |
| 176 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46865783 |
| 177 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.46597230 |
| 178 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46452212 |
| 179 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.45636515 |
| 180 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.45560699 |
| 181 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.45209773 |
| 182 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.44669921 |
| 183 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.43780340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.51156820 |
| 2 | MP0005360_urolithiasis | 7.50879799 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.71512844 |
| 4 | MP0005365_abnormal_bile_salt | 5.37541179 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.63127371 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.27095508 |
| 7 | MP0000566_synostosis | 3.83670188 |
| 8 | MP0003646_muscle_fatigue | 3.77062080 |
| 9 | MP0003252_abnormal_bile_duct | 3.55412017 |
| 10 | MP0000569_abnormal_digit_pigmentation | 3.42167687 |
| 11 | MP0009840_abnormal_foam_cell | 3.34647612 |
| 12 | MP0003195_calcinosis | 3.25900639 |
| 13 | MP0003303_peritoneal_inflammation | 3.25171281 |
| 14 | MP0010329_abnormal_lipoprotein_level | 3.04780280 |
| 15 | MP0005332_abnormal_amino_acid | 3.04764803 |
| 16 | MP0004145_abnormal_muscle_electrophysio | 2.90248381 |
| 17 | MP0002102_abnormal_ear_morphology | 2.62100278 |
| 18 | MP0000383_abnormal_hair_follicle | 2.49244733 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.46317273 |
| 20 | MP0005083_abnormal_biliary_tract | 2.43800184 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 2.41182827 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.33687026 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 2.32184322 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 2.29586780 |
| 25 | MP0001664_abnormal_digestion | 2.27930281 |
| 26 | MP0000427_abnormal_hair_cycle | 2.04583344 |
| 27 | MP0010678_abnormal_skin_adnexa | 2.02115849 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 2.01523153 |
| 29 | MP0000609_abnormal_liver_physiology | 1.90406245 |
| 30 | MP0002254_reproductive_system_inflammat | 1.75622941 |
| 31 | MP0008872_abnormal_physiological_respon | 1.71406470 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.69797718 |
| 33 | MP0003868_abnormal_feces_composition | 1.67991416 |
| 34 | MP0000604_amyloidosis | 1.65846616 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.61938214 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.61533761 |
| 37 | MP0001663_abnormal_digestive_system | 1.56996796 |
| 38 | MP0004215_abnormal_myocardial_fiber | 1.56681160 |
| 39 | MP0005451_abnormal_body_composition | 1.56087201 |
| 40 | MP0001919_abnormal_reproductive_system | 1.54821674 |
| 41 | MP0003329_amyloid_beta_deposits | 1.52473773 |
| 42 | MP0001764_abnormal_homeostasis | 1.48753004 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 1.45707528 |
| 44 | MP0004484_altered_response_of | 1.39542603 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.39028630 |
| 46 | MP0003690_abnormal_glial_cell | 1.38395156 |
| 47 | MP0005253_abnormal_eye_physiology | 1.35346353 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.34958164 |
| 49 | MP0000372_irregular_coat_pigmentation | 1.32548560 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.32434084 |
| 51 | MP0003186_abnormal_redox_activity | 1.32264205 |
| 52 | MP0009046_muscle_twitch | 1.30617047 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.28633665 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.21031069 |
| 55 | MP0005636_abnormal_mineral_homeostasis | 1.20359083 |
| 56 | MP0005058_abnormal_lysosome_morphology | 1.19464406 |
| 57 | MP0004084_abnormal_cardiac_muscle | 1.18378085 |
| 58 | MP0005646_abnormal_pituitary_gland | 1.18242543 |
| 59 | MP0005389_reproductive_system_phenotype | 1.17446072 |
| 60 | MP0003045_fibrosis | 1.17229850 |
| 61 | MP0009780_abnormal_chondrocyte_physiolo | 1.16189277 |
| 62 | MP0003011_delayed_dark_adaptation | 1.15699526 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.13710491 |
| 64 | MP0002909_abnormal_adrenal_gland | 1.12065392 |
| 65 | MP0005381_digestive/alimentary_phenotyp | 1.10935780 |
| 66 | MP0000920_abnormal_myelination | 1.08885233 |
| 67 | MP0002095_abnormal_skin_pigmentation | 1.08269921 |
| 68 | MP0009745_abnormal_behavioral_response | 1.07163246 |
| 69 | MP0004043_abnormal_pH_regulation | 1.05723811 |
| 70 | MP0005620_abnormal_muscle_contractility | 1.04944198 |
| 71 | MP0002272_abnormal_nervous_system | 1.04351562 |
| 72 | MP0005647_abnormal_sex_gland | 1.02758847 |
| 73 | MP0002751_abnormal_autonomic_nervous | 1.02739694 |
| 74 | MP0002332_abnormal_exercise_endurance | 1.02432146 |
| 75 | MP0005671_abnormal_response_to | 1.02020569 |
| 76 | MP0000467_abnormal_esophagus_morphology | 1.00758149 |
| 77 | MP0010386_abnormal_urinary_bladder | 0.99227154 |
| 78 | MP0009764_decreased_sensitivity_to | 0.97895995 |
| 79 | MP0009697_abnormal_copulation | 0.96731439 |
| 80 | MP0000598_abnormal_liver_morphology | 0.94913851 |
| 81 | MP0001440_abnormal_grooming_behavior | 0.94811073 |
| 82 | MP0005174_abnormal_tail_pigmentation | 0.94139808 |
| 83 | MP0004142_abnormal_muscle_tone | 0.94076028 |
| 84 | MP0004036_abnormal_muscle_relaxation | 0.92940070 |
| 85 | MP0001968_abnormal_touch/_nociception | 0.92628285 |
| 86 | MP0002638_abnormal_pupillary_reflex | 0.92248293 |
| 87 | MP0004134_abnormal_chest_morphology | 0.91285880 |
| 88 | MP0002735_abnormal_chemical_nociception | 0.91047851 |
| 89 | MP0008775_abnormal_heart_ventricle | 0.91021579 |
| 90 | MP0008469_abnormal_protein_level | 0.89239849 |
| 91 | MP0004270_analgesia | 0.88554892 |
| 92 | MP0002733_abnormal_thermal_nociception | 0.88420695 |
| 93 | MP0006082_CNS_inflammation | 0.88263313 |
| 94 | MP0001756_abnormal_urination | 0.88117020 |
| 95 | MP0002693_abnormal_pancreas_physiology | 0.86330405 |
| 96 | MP0001661_extended_life_span | 0.84921713 |
| 97 | MP0009763_increased_sensitivity_to | 0.84890710 |
| 98 | MP0002796_impaired_skin_barrier | 0.83618573 |
| 99 | MP0001790_abnormal_immune_system | 0.82641302 |
| 100 | MP0005387_immune_system_phenotype | 0.82641302 |
| 101 | MP0000015_abnormal_ear_pigmentation | 0.81117207 |
| 102 | MP0009642_abnormal_blood_homeostasis | 0.80979252 |
| 103 | MP0001485_abnormal_pinna_reflex | 0.79294706 |
| 104 | MP0002234_abnormal_pharynx_morphology | 0.79217246 |
| 105 | MP0004924_abnormal_behavior | 0.78724479 |
| 106 | MP0005386_behavior/neurological_phenoty | 0.78724479 |
| 107 | MP0006276_abnormal_autonomic_nervous | 0.78616190 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.77029240 |
| 109 | MP0005535_abnormal_body_temperature | 0.76698757 |
| 110 | MP0001800_abnormal_humoral_immune | 0.76411721 |
| 111 | MP0002734_abnormal_mechanical_nocicepti | 0.76370376 |
| 112 | MP0002136_abnormal_kidney_physiology | 0.75389577 |
| 113 | MP0002064_seizures | 0.75332027 |
| 114 | MP0005408_hypopigmentation | 0.75040030 |
| 115 | MP0006036_abnormal_mitochondrial_physio | 0.74361047 |
| 116 | MP0003879_abnormal_hair_cell | 0.71230462 |
| 117 | MP0000749_muscle_degeneration | 0.70691169 |
| 118 | MP0005376_homeostasis/metabolism_phenot | 0.70677534 |
| 119 | MP0001835_abnormal_antigen_presentation | 0.70215148 |
| 120 | MP0000631_abnormal_neuroendocrine_gland | 0.68942749 |
| 121 | MP0002009_preneoplasia | 0.68702786 |
| 122 | MP0004381_abnormal_hair_follicle | 0.67165188 |
| 123 | MP0000579_abnormal_nail_morphology | 0.64782619 |
| 124 | MP0001765_abnormal_ion_homeostasis | 0.64750681 |
| 125 | MP0005084_abnormal_gallbladder_morpholo | 0.64097643 |
| 126 | MP0003075_altered_response_to | 0.63965304 |
| 127 | MP0002971_abnormal_brown_adipose | 0.63649814 |
| 128 | MP0002078_abnormal_glucose_homeostasis | 0.63606204 |
| 129 | MP0003705_abnormal_hypodermis_morpholog | 0.62478812 |
| 130 | MP0005220_abnormal_exocrine_pancreas | 0.58131456 |
| 131 | MP0009384_cardiac_valve_regurgitation | 0.54739813 |
| 132 | MP0002822_catalepsy | 0.54481509 |
| 133 | MP0010234_abnormal_vibrissa_follicle | 0.54440501 |
| 134 | MP0003638_abnormal_response/metabolism_ | 0.54148843 |
| 135 | MP0005334_abnormal_fat_pad | 0.53726325 |
| 136 | MP0005395_other_phenotype | 0.52331259 |
| 137 | MP0008874_decreased_physiological_sensi | 0.51767837 |
| 138 | MP0005266_abnormal_metabolism | 0.49459138 |
| 139 | MP0004885_abnormal_endolymph | 0.48245137 |
| 140 | MP0000639_abnormal_adrenal_gland | 0.47865301 |
| 141 | MP0000230_abnormal_systemic_arterial | 0.47857441 |
| 142 | MP0002295_abnormal_pulmonary_circulatio | 0.47379975 |
| 143 | MP0006035_abnormal_mitochondrial_morpho | 0.47357504 |
| 144 | MP0004130_abnormal_muscle_cell | 0.46469087 |
| 145 | MP0003724_increased_susceptibility_to | 0.45646973 |
| 146 | MP0000538_abnormal_urinary_bladder | 0.45042081 |
| 147 | MP0004147_increased_porphyrin_level | 0.44684009 |
| 148 | MP0003718_maternal_effect | 0.43410706 |
| 149 | MP0003453_abnormal_keratinocyte_physiol | 0.42937585 |
| 150 | MP0003632_abnormal_nervous_system | 0.41905360 |
| 151 | MP0002168_other_aberrant_phenotype | 0.41599047 |
| 152 | MP0005166_decreased_susceptibility_to | 0.41366899 |
| 153 | MP0005448_abnormal_energy_balance | 0.41093756 |
| 154 | MP0008873_increased_physiological_sensi | 0.40491120 |
| 155 | MP0001243_abnormal_dermal_layer | 0.40354683 |
| 156 | MP0002090_abnormal_vision | 0.38914041 |
| 157 | MP0000685_abnormal_immune_system | 0.38775241 |
| 158 | MP0004947_skin_inflammation | 0.38420976 |
| 159 | MP0003436_decreased_susceptibility_to | 0.38406926 |
| 160 | MP0002060_abnormal_skin_morphology | 0.38343910 |
| 161 | MP0003633_abnormal_nervous_system | 0.37962302 |
| 162 | MP0010368_abnormal_lymphatic_system | 0.37156052 |
| 163 | MP0002928_abnormal_bile_duct | 0.35774895 |
| 164 | MP0005464_abnormal_platelet_physiology | 0.34722296 |
| 165 | MP0003172_abnormal_lysosome_physiology | 0.34619969 |
| 166 | MP0001845_abnormal_inflammatory_respons | 0.34108693 |
| 167 | MP0000647_abnormal_sebaceous_gland | 0.33538790 |
| 168 | MP0005670_abnormal_white_adipose | 0.33354141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.80999860 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.64185758 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.09030230 |
| 4 | Xanthomatosis (HP:0000991) | 5.83876727 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.57162134 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.28644026 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.14918707 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.82047607 |
| 9 | Complement deficiency (HP:0004431) | 4.81803375 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.32100285 |
| 11 | Epidermoid cyst (HP:0200040) | 4.26392233 |
| 12 | Large for gestational age (HP:0001520) | 4.21081381 |
| 13 | Hyperammonemia (HP:0001987) | 4.12446793 |
| 14 | Ketosis (HP:0001946) | 4.02796269 |
| 15 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.02144780 |
| 16 | Hyperglycinemia (HP:0002154) | 4.00172907 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 3.96634945 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.96634945 |
| 19 | Hyperglycinuria (HP:0003108) | 3.90921527 |
| 20 | Fat malabsorption (HP:0002630) | 3.90735713 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.90450977 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.79177264 |
| 23 | Joint hemorrhage (HP:0005261) | 3.77569859 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.70799869 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.65658000 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.56066059 |
| 27 | Abnormality of complement system (HP:0005339) | 3.48246293 |
| 28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.44351347 |
| 29 | Hyperventilation (HP:0002883) | 3.37852838 |
| 30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.35603887 |
| 31 | Broad-based gait (HP:0002136) | 3.34543784 |
| 32 | Decreased circulating renin level (HP:0003351) | 3.27476017 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 3.24916137 |
| 34 | Abnormality of midbrain morphology (HP:0002418) | 3.24699389 |
| 35 | Molar tooth sign on MRI (HP:0002419) | 3.24699389 |
| 36 | Pancreatic cysts (HP:0001737) | 3.23712858 |
| 37 | Hypoglycemic coma (HP:0001325) | 3.13379689 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 3.10865257 |
| 39 | Steatorrhea (HP:0002570) | 3.10064846 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.06819451 |
| 41 | Progressive inability to walk (HP:0002505) | 3.05112112 |
| 42 | Ketoacidosis (HP:0001993) | 3.04374700 |
| 43 | True hermaphroditism (HP:0010459) | 3.01563653 |
| 44 | Renal cortical cysts (HP:0000803) | 2.97875733 |
| 45 | Gout (HP:0001997) | 2.97441777 |
| 46 | Hypercholesterolemia (HP:0003124) | 2.97061573 |
| 47 | Abnormality of the renal collecting system (HP:0004742) | 2.93149656 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.86533832 |
| 49 | Abolished electroretinogram (ERG) (HP:0000550) | 2.84133169 |
| 50 | Delayed CNS myelination (HP:0002188) | 2.84126745 |
| 51 | Duplicated collecting system (HP:0000081) | 2.84007321 |
| 52 | Hyperbilirubinemia (HP:0002904) | 2.81138139 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.81094084 |
| 54 | Abnormality of the renal cortex (HP:0011035) | 2.80554458 |
| 55 | Neurofibrillary tangles (HP:0002185) | 2.77729705 |
| 56 | Pancreatic fibrosis (HP:0100732) | 2.73936280 |
| 57 | Severe muscular hypotonia (HP:0006829) | 2.73699300 |
| 58 | Myocardial infarction (HP:0001658) | 2.70283922 |
| 59 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.70214587 |
| 60 | Systemic lupus erythematosus (HP:0002725) | 2.69612421 |
| 61 | Inability to walk (HP:0002540) | 2.64872197 |
| 62 | Metabolic acidosis (HP:0001942) | 2.64107629 |
| 63 | Vascular calcification (HP:0004934) | 2.62884292 |
| 64 | Abnormality of serum amino acid levels (HP:0003112) | 2.62368718 |
| 65 | Calf muscle hypertrophy (HP:0008981) | 2.60584979 |
| 66 | Type II lissencephaly (HP:0007260) | 2.52533854 |
| 67 | Abnormal gallbladder morphology (HP:0012437) | 2.50554475 |
| 68 | Lethargy (HP:0001254) | 2.50552068 |
| 69 | Congenital stationary night blindness (HP:0007642) | 2.49289441 |
| 70 | Hepatocellular carcinoma (HP:0001402) | 2.47617460 |
| 71 | Alkalosis (HP:0001948) | 2.47429377 |
| 72 | Furrowed tongue (HP:0000221) | 2.47011784 |
| 73 | Metabolic alkalosis (HP:0200114) | 2.46722569 |
| 74 | Spontaneous abortion (HP:0005268) | 2.46444655 |
| 75 | Agitation (HP:0000713) | 2.46249385 |
| 76 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.46172785 |
| 77 | Congenital sensorineural hearing impairment (HP:0008527) | 2.45788002 |
| 78 | Hypoplasia of the fovea (HP:0007750) | 2.44823038 |
| 79 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.44823038 |
| 80 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.44413316 |
| 81 | Dicarboxylic aciduria (HP:0003215) | 2.44413316 |
| 82 | Irritability (HP:0000737) | 2.43841231 |
| 83 | Abnormal gallbladder physiology (HP:0012438) | 2.42506728 |
| 84 | Cholecystitis (HP:0001082) | 2.42506728 |
| 85 | Skin nodule (HP:0200036) | 2.40427635 |
| 86 | Mitral stenosis (HP:0001718) | 2.35977039 |
| 87 | Amyloidosis (HP:0011034) | 2.35630529 |
| 88 | Cholelithiasis (HP:0001081) | 2.35151146 |
| 89 | Nemaline bodies (HP:0003798) | 2.35079637 |
| 90 | Cardiovascular calcification (HP:0011915) | 2.34975298 |
| 91 | Muscle fiber inclusion bodies (HP:0100299) | 2.34083500 |
| 92 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.32713946 |
| 93 | Fair hair (HP:0002286) | 2.32549201 |
| 94 | Cerebral edema (HP:0002181) | 2.30723492 |
| 95 | Rickets (HP:0002748) | 2.30027760 |
| 96 | Widely spaced teeth (HP:0000687) | 2.29701191 |
| 97 | Hypophosphatemic rickets (HP:0004912) | 2.29447457 |
| 98 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.29152764 |
| 99 | Abnormality of alanine metabolism (HP:0010916) | 2.29152764 |
| 100 | Hyperalaninemia (HP:0003348) | 2.29152764 |
| 101 | Gaze-evoked nystagmus (HP:0000640) | 2.27684864 |
| 102 | Generalized aminoaciduria (HP:0002909) | 2.27562851 |
| 103 | Hypochromic microcytic anemia (HP:0004840) | 2.27459680 |
| 104 | Congenital, generalized hypertrichosis (HP:0004540) | 2.26882273 |
| 105 | Conjunctival hamartoma (HP:0100780) | 2.26427192 |
| 106 | Hydroxyprolinuria (HP:0003080) | 2.26062824 |
| 107 | Abnormality of proline metabolism (HP:0010907) | 2.26062824 |
| 108 | Palmoplantar hyperkeratosis (HP:0000972) | 2.24291215 |
| 109 | Sensorimotor neuropathy (HP:0007141) | 2.23630726 |
| 110 | Chronic hepatic failure (HP:0100626) | 2.23571876 |
| 111 | Abnormality of vitamin B metabolism (HP:0004340) | 2.23381249 |
| 112 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.22528094 |
| 113 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.22348935 |
| 114 | Malnutrition (HP:0004395) | 2.22217280 |
| 115 | Nephronophthisis (HP:0000090) | 2.20035669 |
| 116 | Vomiting (HP:0002013) | 2.18961996 |
| 117 | Spastic paraparesis (HP:0002313) | 2.18781916 |
| 118 | Palmar hyperkeratosis (HP:0010765) | 2.17989346 |
| 119 | Abnormality of glycolipid metabolism (HP:0010969) | 2.17338403 |
| 120 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.17338403 |
| 121 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.17338403 |
| 122 | Cerebral inclusion bodies (HP:0100314) | 2.16420748 |
| 123 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.15218971 |
| 124 | Abnormality of the fovea (HP:0000493) | 2.14542473 |
| 125 | Opisthotonus (HP:0002179) | 2.13285895 |
| 126 | Hypoplastic pelvis (HP:0008839) | 2.12892045 |
| 127 | Methylmalonic acidemia (HP:0002912) | 2.12231214 |
| 128 | Chorioretinal atrophy (HP:0000533) | 2.12180967 |
| 129 | Hypokalemia (HP:0002900) | 2.11665872 |
| 130 | Methylmalonic aciduria (HP:0012120) | 2.08653222 |
| 131 | Attenuation of retinal blood vessels (HP:0007843) | 2.06476435 |
| 132 | Brushfield spots (HP:0001088) | 2.06424272 |
| 133 | Plantar hyperkeratosis (HP:0007556) | 2.06164823 |
| 134 | Acanthocytosis (HP:0001927) | 2.04675463 |
| 135 | Increased purine levels (HP:0004368) | 2.04498012 |
| 136 | Hyperuricemia (HP:0002149) | 2.04498012 |
| 137 | Neonatal onset (HP:0003623) | 2.04335218 |
| 138 | Glomerulonephritis (HP:0000099) | 2.04235662 |
| 139 | Proximal tubulopathy (HP:0000114) | 2.03694250 |
| 140 | Tubular atrophy (HP:0000092) | 2.03422563 |
| 141 | Abnormality of the gallbladder (HP:0005264) | 2.03324127 |
| 142 | Hypoplastic iliac wings (HP:0002866) | 2.02141332 |
| 143 | Glycosuria (HP:0003076) | 2.01740754 |
| 144 | Abnormality of urine glucose concentration (HP:0011016) | 2.01740754 |
| 145 | Lissencephaly (HP:0001339) | 2.00677615 |
| 146 | Generalized hypopigmentation of hair (HP:0011358) | 2.00294301 |
| 147 | Spastic diplegia (HP:0001264) | 2.00088899 |
| 148 | Absent speech (HP:0001344) | 1.99735711 |
| 149 | Hypoglycemic seizures (HP:0002173) | 1.99486899 |
| 150 | Myoglobinuria (HP:0002913) | 1.98898057 |
| 151 | Protuberant abdomen (HP:0001538) | 1.98002429 |
| 152 | Abnormality of the renal medulla (HP:0100957) | 1.97587743 |
| 153 | Long foot (HP:0001833) | 1.96842549 |
| 154 | Elevated alkaline phosphatase (HP:0003155) | 1.96383089 |
| 155 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.95849349 |
| 156 | Vacuolated lymphocytes (HP:0001922) | 1.94034107 |
| 157 | Pancreatitis (HP:0001733) | 1.93909563 |
| 158 | Abnormality of renin-angiotensin system (HP:0000847) | 1.93458029 |
| 159 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.92660375 |
| 160 | Confusion (HP:0001289) | 1.91911153 |
| 161 | Enlarged kidneys (HP:0000105) | 1.91427642 |
| 162 | Abnormality of potassium homeostasis (HP:0011042) | 1.90924180 |
| 163 | Cerebral hemorrhage (HP:0001342) | 1.90867085 |
| 164 | Dry hair (HP:0011359) | 1.89593706 |
| 165 | Pendular nystagmus (HP:0012043) | 1.88613336 |
| 166 | Polymicrogyria (HP:0002126) | 1.88302546 |
| 167 | Hypoalbuminemia (HP:0003073) | 1.87342543 |
| 168 | Abnormal albumin level (HP:0012116) | 1.87342543 |
| 169 | Long nose (HP:0003189) | 1.87067022 |
| 170 | Late onset (HP:0003584) | 1.86199914 |
| 171 | Hypoplastic nipples (HP:0002557) | 1.85531438 |
| 172 | Hemiparesis (HP:0001269) | 1.85517794 |
| 173 | Gingival bleeding (HP:0000225) | 1.85223211 |
| 174 | Paraparesis (HP:0002385) | 1.84579224 |
| 175 | Absent/shortened dynein arms (HP:0200106) | 1.84337233 |
| 176 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.84337233 |
| 177 | Medial flaring of the eyebrow (HP:0010747) | 1.83226852 |
| 178 | Axonal loss (HP:0003447) | 1.83225403 |
| 179 | Adactyly (HP:0009776) | 1.82695706 |
| 180 | Hypokalemic alkalosis (HP:0001949) | 1.80603893 |
| 181 | Hamartoma of the eye (HP:0010568) | 1.79509495 |
| 182 | Clubbing of toes (HP:0100760) | 1.79487827 |
| 183 | Abnormality of B cell number (HP:0010975) | 1.75257604 |
| 184 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.74581437 |
| 185 | Abnormality of vitamin metabolism (HP:0100508) | 1.72808962 |
| 186 | Goiter (HP:0000853) | 1.72620184 |
| 187 | Keratoconus (HP:0000563) | 1.71461734 |
| 188 | Increased corneal curvature (HP:0100692) | 1.71461734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MKNK2 | 6.97632366 |
| 2 | BCKDK | 5.08955527 |
| 3 | TAOK1 | 4.43387602 |
| 4 | MKNK1 | 3.72110148 |
| 5 | FGFR4 | 3.59315254 |
| 6 | ERN1 | 3.34175843 |
| 7 | OXSR1 | 3.32942616 |
| 8 | ACVR1B | 3.28465297 |
| 9 | EPHB1 | 3.21635346 |
| 10 | TAOK3 | 3.20790899 |
| 11 | ADRBK2 | 3.15758015 |
| 12 | STK39 | 3.06612280 |
| 13 | ERBB4 | 2.93847174 |
| 14 | WNK4 | 2.60297165 |
| 15 | OBSCN | 2.30782516 |
| 16 | SIK1 | 2.30642608 |
| 17 | INSRR | 2.22063480 |
| 18 | MAP3K3 | 2.18375383 |
| 19 | TLK1 | 2.08953813 |
| 20 | TAOK2 | 2.08804147 |
| 21 | MAP3K11 | 2.06430462 |
| 22 | MAP3K14 | 1.93083362 |
| 23 | PHKG1 | 1.83760005 |
| 24 | PHKG2 | 1.83760005 |
| 25 | WNK3 | 1.80597726 |
| 26 | MET | 1.74484931 |
| 27 | PKN1 | 1.65083469 |
| 28 | TYK2 | 1.59607918 |
| 29 | MAP2K3 | 1.54024055 |
| 30 | GRK1 | 1.48961804 |
| 31 | MAP2K4 | 1.47316841 |
| 32 | FGFR2 | 1.40662300 |
| 33 | MST4 | 1.36849207 |
| 34 | MST1R | 1.36363616 |
| 35 | BCR | 1.33091768 |
| 36 | CASK | 1.31865647 |
| 37 | MAPK11 | 1.31699055 |
| 38 | PIK3CG | 1.30620274 |
| 39 | MAP3K4 | 1.30525953 |
| 40 | MAP3K13 | 1.27699239 |
| 41 | ABL2 | 1.26345053 |
| 42 | JAK3 | 1.22046592 |
| 43 | PBK | 1.21787842 |
| 44 | MAPK15 | 1.21697206 |
| 45 | TBK1 | 1.16477277 |
| 46 | SGK223 | 1.15403086 |
| 47 | SGK494 | 1.15403086 |
| 48 | TRPM7 | 1.11290669 |
| 49 | GRK6 | 1.09959949 |
| 50 | PTK6 | 1.07191878 |
| 51 | SCYL2 | 1.05758234 |
| 52 | ERBB3 | 1.04979843 |
| 53 | EIF2AK3 | 1.00911051 |
| 54 | EPHA3 | 1.00848438 |
| 55 | PINK1 | 0.96368389 |
| 56 | CAMK2G | 0.94646101 |
| 57 | NTRK1 | 0.94112654 |
| 58 | ICK | 0.93477567 |
| 59 | NUAK1 | 0.93041066 |
| 60 | TESK2 | 0.92990744 |
| 61 | MAPK13 | 0.92495356 |
| 62 | JAK2 | 0.92019587 |
| 63 | ADRBK1 | 0.90963261 |
| 64 | MAP3K7 | 0.90086691 |
| 65 | BMPR1B | 0.89228290 |
| 66 | JAK1 | 0.88872745 |
| 67 | PRKCQ | 0.88449071 |
| 68 | EPHA4 | 0.88101109 |
| 69 | MARK1 | 0.86480531 |
| 70 | ZAK | 0.86284944 |
| 71 | PTK2 | 0.83110924 |
| 72 | PRKCZ | 0.82701130 |
| 73 | NEK9 | 0.82031277 |
| 74 | PRKAA2 | 0.80922177 |
| 75 | DYRK1B | 0.80583630 |
| 76 | DAPK2 | 0.80515884 |
| 77 | GSK3A | 0.79560443 |
| 78 | ITK | 0.77329643 |
| 79 | LATS1 | 0.76987556 |
| 80 | FRK | 0.75920469 |
| 81 | FLT3 | 0.75845067 |
| 82 | CSF1R | 0.74790056 |
| 83 | PAK3 | 0.74779158 |
| 84 | DYRK1A | 0.74430765 |
| 85 | CAMKK2 | 0.74376084 |
| 86 | MUSK | 0.73752882 |
| 87 | MAPKAPK3 | 0.73550328 |
| 88 | IRAK1 | 0.72997742 |
| 89 | LIMK1 | 0.71933181 |
| 90 | PDPK1 | 0.70950927 |
| 91 | NEK1 | 0.70947382 |
| 92 | IKBKE | 0.70227240 |
| 93 | FGR | 0.69429009 |
| 94 | IRAK3 | 0.68531149 |
| 95 | MAP2K7 | 0.68357784 |
| 96 | CSK | 0.67616537 |
| 97 | CCNB1 | 0.66721280 |
| 98 | CSNK1G3 | 0.66228425 |
| 99 | GRK7 | 0.65475676 |
| 100 | BLK | 0.65439898 |
| 101 | ARAF | 0.65437606 |
| 102 | EIF2AK1 | 0.65189746 |
| 103 | MAPK4 | 0.64531317 |
| 104 | STK38L | 0.64030217 |
| 105 | CSNK1G1 | 0.63645310 |
| 106 | WNK1 | 0.60813072 |
| 107 | SYK | 0.58306310 |
| 108 | NEK2 | 0.57737849 |
| 109 | CSNK1G2 | 0.56762322 |
| 110 | PRKACG | 0.56250816 |
| 111 | IRAK2 | 0.55958326 |
| 112 | PIK3CA | 0.51395464 |
| 113 | MAPK12 | 0.51325381 |
| 114 | CSNK1A1L | 0.48454619 |
| 115 | CAMK2B | 0.46659688 |
| 116 | MAP3K5 | 0.46404671 |
| 117 | MAP2K1 | 0.46320993 |
| 118 | KSR2 | 0.46131625 |
| 119 | ERBB2 | 0.45565400 |
| 120 | MAP2K6 | 0.45518621 |
| 121 | TGFBR1 | 0.44019038 |
| 122 | MAPK7 | 0.43911266 |
| 123 | KIT | 0.43496917 |
| 124 | FER | 0.42811111 |
| 125 | MAP2K2 | 0.42794730 |
| 126 | MAPKAPK5 | 0.41382749 |
| 127 | CSNK1A1 | 0.41355926 |
| 128 | EGFR | 0.41150303 |
| 129 | STK11 | 0.40233138 |
| 130 | TXK | 0.39909988 |
| 131 | MAP4K2 | 0.39248176 |
| 132 | CHEK2 | 0.38993566 |
| 133 | PRKCH | 0.36854042 |
| 134 | CAMK2A | 0.35386097 |
| 135 | STK3 | 0.34906811 |
| 136 | CDK3 | 0.34701572 |
| 137 | PRKACA | 0.34113897 |
| 138 | PRKD1 | 0.33125914 |
| 139 | PRKCD | 0.32948652 |
| 140 | RPS6KA5 | 0.32816147 |
| 141 | IGF1R | 0.32678704 |
| 142 | IKBKB | 0.32132116 |
| 143 | MAP3K2 | 0.31831839 |
| 144 | PDK1 | 0.31617550 |
| 145 | MELK | 0.31336352 |
| 146 | MAP3K12 | 0.30655559 |
| 147 | DDR2 | 0.30594875 |
| 148 | ABL1 | 0.30475822 |
| 149 | PRKCI | 0.30236172 |
| 150 | PRKCE | 0.29813280 |
| 151 | SGK3 | 0.29513441 |
| 152 | PTK2B | 0.29280581 |
| 153 | BMX | 0.29016806 |
| 154 | PLK2 | 0.28489857 |
| 155 | PRKCA | 0.28450785 |
| 156 | RET | 0.27926821 |
| 157 | CAMK2D | 0.26777777 |
| 158 | PRKCG | 0.26027534 |
| 159 | PRKAA1 | 0.25311689 |
| 160 | TIE1 | 0.22369481 |
| 161 | LYN | 0.18773916 |
| 162 | BMPR2 | 0.18640578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.22925614 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.12767275 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.10041226 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.04092046 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.86034747 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.67842606 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.61982837 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.58203528 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.57384759 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.55881440 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50861513 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.43823894 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.41426149 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35995113 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.35178386 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.21363457 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.19126776 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.10614370 |
| 19 | Asthma_Homo sapiens_hsa05310 | 2.06264070 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.04470317 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02863003 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.01634024 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96681495 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.93040640 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86949428 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.85644182 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.79655678 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.78581352 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.77557564 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77214405 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74291335 |
| 32 | Phototransduction_Homo sapiens_hsa04744 | 1.67355270 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65201046 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64711533 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.58032721 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.54444256 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54314885 |
| 38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.53613847 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52584631 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.52179804 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51373241 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.48874716 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46495988 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.44925161 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44155339 |
| 46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.42237510 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.41350569 |
| 48 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.39198457 |
| 49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.37961238 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37064479 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.33281143 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.31455737 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26543750 |
| 54 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.25647954 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22456246 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21255353 |
| 57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.20335587 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15048885 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.15041047 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.13055829 |
| 61 | Nicotine addiction_Homo sapiens_hsa05033 | 1.12574517 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.11311321 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.11020938 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.10619093 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10156253 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 1.08653586 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03011565 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01839942 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00687073 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00221886 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99107387 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 0.98453165 |
| 73 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93690751 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.88257636 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.85917811 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82479235 |
| 77 | Morphine addiction_Homo sapiens_hsa05032 | 0.81030383 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80023502 |
| 79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75233574 |
| 80 | Renin secretion_Homo sapiens_hsa04924 | 0.74040470 |
| 81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.73593470 |
| 82 | Olfactory transduction_Homo sapiens_hsa04740 | 0.71600655 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70164839 |
| 84 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.68232835 |
| 85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68068429 |
| 86 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67112235 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65944368 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63974915 |
| 89 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61660990 |
| 90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60438678 |
| 91 | Insulin secretion_Homo sapiens_hsa04911 | 0.59259649 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57884724 |
| 93 | GABAergic synapse_Homo sapiens_hsa04727 | 0.56577246 |
| 94 | Long-term depression_Homo sapiens_hsa04730 | 0.56504085 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56422810 |
| 96 | Salivary secretion_Homo sapiens_hsa04970 | 0.53797185 |
| 97 | Lysine degradation_Homo sapiens_hsa00310 | 0.53467906 |
| 98 | Circadian entrainment_Homo sapiens_hsa04713 | 0.53100336 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50818089 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47292057 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45318645 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45231248 |
| 103 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.45054547 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44404231 |
| 105 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.42209146 |
| 106 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41388821 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.41359135 |
| 108 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.40911862 |
| 109 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.38644375 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37998555 |
| 111 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36476835 |
| 112 | Phagosome_Homo sapiens_hsa04145 | 0.32830918 |
| 113 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.31496446 |
| 114 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.29840291 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25024280 |
| 116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.24087599 |
| 117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23851915 |
| 118 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.22249227 |
| 119 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.21689908 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.20194841 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19092922 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.09396261 |
| 123 | Insulin resistance_Homo sapiens_hsa04931 | 0.08960568 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.07290683 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.06240646 |
| 126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.05968530 |
| 127 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.01713691 |
| 128 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.01524100 |
| 129 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.00560920 |
| 130 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1271802 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.1221901 |
| 132 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1214814 |
| 133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1164258 |
| 134 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1020444 |
| 135 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0904597 |
| 136 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0815280 |
| 137 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.0708483 |
| 138 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0641933 |
| 139 | Hepatitis C_Homo sapiens_hsa05160 | -0.0639570 |
| 140 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0531681 |
| 141 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0513288 |
| 142 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0318628 |
| 143 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0296931 |
| 144 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0205490 |

